職務概況
待遇面議
（經常性薪資達 4 萬元或以上）
新北市汐止區
條件要求
語文條件
英文
聽/中等、說/中等、讀/中等、寫/中等
工作經歷
不拘
職務描述
我們是一家專注於抗體藥物研發的公司，致力於推動醫藥創新和改善人類健康，誠邀有志之士加入我們的團隊，共同開拓未來。
工作職責
1. 以細胞為基礎對抗體結合力進行高通量篩選。
2. 開發能穩定表達目標蛋白的細胞株。
3. 設計並執行以細胞為基礎的抗體功能測試平台。
4. 進行細胞培養、流式細胞分析、免疫螢光染色、ELISA等細胞功能測試。
5. 分析實驗結果以及撰寫實驗報告。
6. 根據需要撰寫各種文件和報告，並制定標準操作程序（SOP）。
7. 搜尋相關的參考資料和研究。
8. 維護並管理實驗室設施、耗材和設備。
資格條件
1. 生物學或免疫學相關領域的碩士學位。
2. 具備生物學和免疫學的基本知識，以及對癌症和其他重要疾病之藥物開發有興趣者優先。
3. 具備流式細胞儀豐富經驗者優先考慮。
4. 具有細胞培養、ELISA 實驗或其他細胞功效性試驗的工作經驗。
5. 能夠與其他團隊緊密合作。
6. 歡迎畢業新鮮人。
Responsibilities
1. Conduct cell-based high-throughput screening of antibody binding.
2. Development of cell lines stably expressing target proteins.
3. Design and perform cell-based functional assay platforms.
4. Perform cell culture, flow analysis, immunofluorescence staining, ELISA and other cell-based functional assays.
5. Analyze experiment results and write reports.
6. Generate various documents and reports as required, and write Standard Operating Procedures (SOPs).
7. Searching for related references and studies.
8. Maintain and organize laboratory facilities, consumables, and equipment.
Qualifications
1. M.S. degree in Biology or Immunology-related fields.
2. Preference will be given to candidates with basic knowledge of biology and immunology, and an interest in cancer and drug development.
3. Priority consideration will be given to those with extensive experience in flow cytometry.
4. Working experience in cell culture, ELISA assay or other cell-based functional assays.
5. Able to work closely with other teams.
6. Recent graduates are welcome to apply.
需求人數
1~2人
學歷要求
碩士以上
科系要求
生物學相關
上班時段
日班
休假制度
週休二日
職務類別
Research Assistant
Biotechnology Research and Development Staff
Pharmaceutical Research and Development Staff
新北市汐止區
生化科技研發業
「三鈺生物科技股份有限公司」（簡稱三鈺生技）成立於2015年，是一家專注於治療性抗體藥物開發的創新公司。利用公司專有平台和技術，篩選體細胞超突變（Somatic hypermutation）親和力優化的全人類專一性抗體，做為新穎藥物開發的基石。三鈺生技與國際合作夥伴製藥公司合作，利用包括抗體藥物複合物（antibody drug conjugate, ADC）、藥物遞送和運輸、以及雙特異性/多特異性抗體平台等新興技術平台，旨在開發針對癌症、眼部疾病和免疫疾病等適應症的新穎藥物。
Trican Biotechnology founded in 2015, is an innovative company focused on the development of therapeutic antibody drugs. Leveraging its proprietary platform and technology, Trican screens for affinity-maturated fully human antibodies optimized through somatic hypermutation served as the foundation for novel drug development. Cooperating with emerging technical platforms including antibody-drug conjugates (ADCs), drug delivery and transport, and bi-specific/multi-specific antibodies platform from international partner pharmaceutical companies, Trican aims to develop novel therapeutic drugs for indications such as cancer, ocular disorders, and immune diseases.
三鈺生技緊密結合了研發團隊、商業開發團隊和經營管理團隊，一起帶領公司前進世界藥物開發的舞台。我們的研發團隊專精於抗體藥物開發、免疫學、蛋白質結構、上游（細胞株開發）和下游（製程開發）抗體製造以及生物功能驗證。利用創新技術和平台，能夠高效地發掘腫瘤相關抗原（或其他疾病相關抗原）的高親和力、特異性抗體。我們的商業開發團隊與國內外風險投資公司有著密切聯繫，並擁有藥物開發經驗，帶領公司與全球合作夥伴合作。此外，我們的管理和投資團隊帶來了寶貴的治理專業知識，確保我們保持在正確的商業模式，並與國際趨勢一致，持續為公司創造價值。
Trican Biotechnology closely integrates its research and development team, business development team, and management team to lead the company onto the global stage of drug development. Our research team experts in antibody drug development, immunology, protein structure, upstream (cell development) and downstream (process development) antibody manufacturing, and biological functional validation. Using innovative technology and platforms, we efficiently discover high-affinity, specific antibodies targeting tumor-associated antigens (or other disease-associated antigens). Our business development team with strong association with venture capital of domestic and international company and experience in drug development, lead Trican collaboration with global partners. Additionally, our management and investment team bring valuable governance expertise, ensuring that we stay aligned with right business models and international trends, continuously creating value for the company.
